Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News

Barchart.com
barchart.com > press-releases > 4477518 > osteoarthritis-clinical-trial-pipeline-appears-robust-with-100-key-pharma-companies-actively-working-in-the-therapeutics-segment-delveinsight

Osteoarthritis Clinical Trial Pipeline Appears Robust With 100+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight

5+ day, 11+ hour ago   (80+ words) Key Takeaways from the Osteoarthritis Pipeline Report Get a detailed analysis of the latest innovations in the Osteoarthritis pipeline @ Osteoarthritis Unmet Needs Osteoarthritis Pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have…...

MarketScreener
marketscreener.com > news > eli-lilly-s-psoriasis-drug-trial-shows-sustained-positive-results-ce7858dcd188ff2d

Eli Lilly's Psoriasis Drug Trial Shows Sustained Positive Results

1+ week, 5+ day ago   (212+ words) Published on 08/31/2026 at 08:08 am EDT - Modified on 08/31/2026 at 08:09 am EDT Eli Lilly shared results from two phase 3b clinical trials showing its drug Zepbound could reduce symptoms of psoriasis and psoriatic arthritis for people who are overweight. Zepbound in combination with…...

aHUS News
ahusnews.com > news > approved-treatment-helps-girl-recover-severe-ahus

Approved treatment helps girl recover from severe aHUS

2+ week, 5+ day ago   (345+ words) Ultomiris treatment led to rapid blood and kidney recovery in a girl with severe aHUS associated with a rare genetic mutation, per a report....

openPR.com
openpr.com > news > 4606110 > chemotherapy-induced-peripheral-neuropathy-treatment-market

Chemotherapy Induced Peripheral Neuropathy Treatment Market Analysis Highlights Growth To $2.36 Billion By 2030 At 6.2% CAGR

3+ week, 5+ day ago   (63+ words) Chemotherapy Induced Peripheral Neuropathy Treatment Market openpr.com Chemotherapy Induced Peripheral Neuropathy Treatment Market Analysis Highlights Growth To $2.36 Billion By 2030 At 6.2% CAGR Press release from: The Business Research Company Permanent link to this press release: You can edit or delete…...

KSAL.com
ksal.com > alpha-performance-health-opens-in-salina

Alpha Performance Health Opens in Salina

3+ week, 5+ day ago   (133+ words) A Spring Hill based wellness clinic celebrated the opening of a Salina location Monday. Staff, supporters, and the Salina Area Chamber of Commerce Blue Coats gathered for a ribbon cutting at Alpha Performance Health, located at 1823 South Ohio. Dr. Ptacek…...

Medical Xpress
medicalxpress.com > news > 2026-08-mathematical-personalize-therapy-prostate-cancer.html

medicalxpress.com

4+ week, 2+ day ago   (13+ words) Researchers develop mathematical measures to better personalize therapy for prostate cancer Medical Xpress...

ARY News
arynews.tv > moonlakes-psoriatic-arthritis-drug-meets-key-goals.amp

MoonLake's psoriatic arthritis drug meets key goals in late-stage trial

1+ mon, 2+ day ago   (314+ words) ARYnews.tv MoonLake's psoriatic arthritis drug meets key goals in late-stage trial MoonLake Immunotherapeutics said on Monday its experimental drug met all ​main goals in a late-stage trial involving adults with an inflammatory disease who had not previously received biologic…...

Google News
cureus.com > articles > 516584-tocilizumab-therapy-and-incident-depression-in-rheumatoid-arthritis-a-retrospective-cohort-study-of-the-all-of-us-research-program

Tocilizumab Therapy and Incident Depression in Rheumatoid Arthritis: A Retrospective Cohort Study of the All of Us Research Program | Cureus

1+ mon, 1+ week ago   (51+ words) Tocilizumab Therapy and Incident Depression in Rheumatoid Arthritis: A Retrospective Cohort Study of the All of Us Research Program cureus.com Please note that by doing so you agree to be added to our monthly email newsletter distribution list. Download…...

Medical University of Vienna
meduniwien.ac.at > web > en > about-us > news > 2026 > news-in-july-2026 > rheumatoid-arthritis-early-immune-changes-during-methotrexate-treatment-may-predict-treatment-success

Rheumatoid arthritis: Early immune changes during methotrexate treatment may predict treatment success | MedUni Vienna

1+ mon, 1+ week ago   (225+ words) The study combines state-of-the-art single-cell RNA sequencing with advanced immunophenotyping to track changes in immune cell populations and molecular signalling pathways in patients from the start of MTX treatment onwards. "Our findings provide a detailed picture of how patients’ immune…...

Conexiant
conexiant.com > rheumatology > articles > serostatus-may-modify-ra-activity-cv-link

Serostatus May Modify RA Activity–CV Link

1+ mon, 4+ week ago   (340+ words) Higher rheumatoid arthritis disease activity at study entry was associated with a greater risk of a first major adverse cardiovascular event, but the strength of that association differed according to patients’ combined rheumatoid factor and anticitrullinated protein antibody status. Researchers…...